Driving Restrictions in Patients with Implantable Cardioverter Defibrillators and Pacemakers

Overview

Journal J Arrhythm

Publisher Wiley

Date 2017 Dec 20

PMID 29255507

Citations 4

Authors

Eiichi Watanabe

Haruhiko Abe

Shigeyuki Watanabe

Affiliations

Soon will be listed here.

Abstract

Implantable cardioverter-defibrillators (ICDs) improve the survival in patients at risk of sudden cardiac death. However, these patients have an ongoing risk of sudden incapacitation that may cause harm to individuals and others when driving. Considerable disagreement exists about whether and when these patients should be allowed to resume driving after ICD therapies. This information is critical for the management decisions to avoid future potentially lethal incidents and unnecessary restrictions for ICD patients. The cardiac implantable device committee of the Japanese Heart Rhythm Society reassessed the risk of driving for ICD patients based on the literature and domestic data. We reviewed the driving restrictions of ICD patients in various regions and here present updated Japanese driving restrictions.

Citing Articles

A Review of Driving Restrictions in Patients at Risk of Syncope and Cardiac Arrhythmias Associated with Sudden Incapacity: Differing Global Approaches to Regulation and Risk.

Margulescu A, Anderson M Arrhythm Electrophysiol Rev. 2019; 8(2):90-98.

PMID: 31114682 PMC: 6528027. DOI: 10.15420/aer.2019.13.2.

[Fitness to drive in patients with cardiovascular implantable electronic devices].

Mijic D, Lemke B, Bogossian H Herzschrittmacherther Elektrophysiol. 2019; 30(2):150-155.

PMID: 31073643 DOI: 10.1007/s00399-019-0626-y.

Do we understand the rationale behind driving restrictions in patients with an implantable cardioverter defibrillator?.

Baalman S, de Groot J Neth Heart J. 2018; 26(2):53-54.

PMID: 29330685 PMC: 5783895. DOI: 10.1007/s12471-017-1072-2.

Inappropriate implantable cardioverter defibrillator shocks-incidence, effect, and implications for driver licensing.

Watanabe E, Okajima K, Shimane A, Ozawa T, Manaka T, Morishima I J Interv Card Electrophysiol. 2017; 49(3):271-280.

PMID: 28730420 PMC: 5543197. DOI: 10.1007/s10840-017-0272-4.

References

Freedberg N, Hill J, Fogel R, Prystowsky E . Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group. J Am Coll Cardiol. 2001; 37(7):1910-5. DOI: 10.1016/s0735-1097(01)01226-8. View

Hickey K, Curtis A, Lancaster S, Larsen G, Warwick D, McAnulty J . Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. Am Heart J. 2001; 142(1):99-104. DOI: 10.1067/mhj.2001.115787. View

Akiyama T, Powell J, Mitchell L, Ehlert F, Baessler C . Resumption of driving after life-threatening ventricular tachyarrhythmia. N Engl J Med. 2001; 345(6):391-7. DOI: 10.1056/NEJM200108093450601. View

Wathen M, Sweeney M, DeGroot P, Stark A, Koehler J, Chisner M . Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation. 2001; 104(7):796-801. DOI: 10.1161/hc3101.093906. View

Eckert M, Jones T . How does an implantable cardioverter defibrillator (ICD) affect the lives of patients and their families?. Int J Nurs Pract. 2002; 8(3):152-7. DOI: 10.1046/j.1440-172x.2002.00357.x. View

Soteriades E, Evans J, Larson M, Chen M, Chen L, Benjamin E . Incidence and prognosis of syncope. N Engl J Med. 2002; 347(12):878-85. DOI: 10.1056/NEJMoa012407. View

Lampert R, Joska T, Burg M, Batsford W, McPherson C, Jain D . Emotional and physical precipitants of ventricular arrhythmia. Circulation. 2002; 106(14):1800-5. DOI: 10.1161/01.cir.0000031733.51374.c1. View

Blitzer M, Saliba B, Ghantous A, Marieb M, Schoenfeld M . Causes of impaired consciousness while driving a motorized vehicle. Am J Cardiol. 2003; 91(11):1373-4. DOI: 10.1016/s0002-9149(03)00336-9. View

Klein R, Raitt M, Wilkoff B, Beckman K, Coromilas J, Wyse D . Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol. 2003; 14(9):940-8. DOI: 10.1046/j.1540-8167.2003.01554.x. View

10.

Wathen M, DeGroot P, Sweeney M, Stark A, Otterness M, Adkisson W . Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock.... Circulation. 2004; 110(17):2591-6. DOI: 10.1161/01.CIR.0000145610.64014.E4. View

11.

Simpson C, Dorian P, Gupta A, Hamilton R, Hart S, Hoffmaster B . Assessment of the cardiac patient for fitness to drive: drive subgroup executive summary. Can J Cardiol. 2004; 20(13):1314-20. View

12.

Baessler C, Murphy S, Gebhardt L, Tso T, Ellenbogen K, Leman R . Time to resumption of driving after implantation of an automatic defibrillator (from the Dual chamber and VVI Implantable Defibrillator [DAVID] trial). Am J Cardiol. 2005; 95(5):665-6. DOI: 10.1016/j.amjcard.2004.10.048. View

13.

Lerecouvreux M, Ait Said M, Paziaud O, Perrier E, Carlioz R, Lavergne T . [Automobile driving and implantable defibrillators]. Arch Mal Coeur Vaiss. 2005; 98(4):288-93. View

14.

. Assessment of the cardiac patient for fitness to drive. Can J Cardiol. 1992; 8(4):406-19. View

15.

Germano J, Reynolds M, Essebag V, Josephson M . Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?. Am J Cardiol. 2006; 97(8):1255-61. DOI: 10.1016/j.amjcard.2005.11.048. View

16.

Wilkoff B, Ousdigian K, Sterns L, Wang Z, Wilson R, Morgan J . A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol. 2006; 48(2):330-9. DOI: 10.1016/j.jacc.2006.03.037. View

17.

Epstein A, Baessler C, Curtis A, Estes 3rd N, Gersh B, Grubb B . Addendum to "Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American.... Circulation. 2007; 115(9):1170-6. DOI: 10.1161/CIRCULATIONAHA.106.180203. View

18.

Albert C, Rosenthal L, Calkins H, Steinberg J, Ruskin J, Wang P . Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study. J Am Coll Cardiol. 2007; 50(23):2233-40. DOI: 10.1016/j.jacc.2007.06.059. View

19.

Wilkoff B, Williamson B, Stern R, Moore S, Lu F, Lee S . Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol. 2008; 52(7):541-50. DOI: 10.1016/j.jacc.2008.05.011. View

20.

Kou W, Calkins H, Lewis R, Bolling S, Kirsch M, Langberg J . Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks. Ann Intern Med. 1991; 115(12):942-5. DOI: 10.7326/0003-4819-115-12-942. View